[1] https://www.who.int/podcasts/episode/science-in-5/episode--122---dementia
[2] Uptodate: Evaluation of cognitive impairment and dementia.
[3] Arroll B, Khin N, Kerse N. Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ 2003; 327:1144.
[4] Uptodate: Evaluation of cognitive impairment and dementia.
[5] Tinetti ME, McAvay GJ, Murphy TE, et al. Contribution of individual diseases to death in older adults with multiple diseases. J Am Geriatr Soc 2012; 60:1448.
[6] Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020; 396:413.
[7] Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet 2017; 390:2673.
[8] Uptodate: Mild cognitive impairment: Prognosis and treatment.
[9] Russ TC, Morling JR. Cholinesterase inhibitors for mild cognitive impairment. Cochrane Database Syst Rev 2012; :CD009132.
[10] Ströhle A, Schmidt DK, Schultz F, et al. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials. Am J Geriatr Psychiatry 2015; 23:1234.
[11] Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 2006; :CD006104.